A first-in-human phase Ia/b, open-label, multicentre, dose-escalation study of BI 905711 in patients with advanced gastrointestinal cancers Meeting Abstract
| Authors: | Harding, J.; Hofheinz, R.; Elez, E.; Kuboki, Y.; Geng, J.; Schmohl, M.; Dowling, E.; Feng, Y.; Rasco, D. |
| Abstract Title: | A first-in-human phase Ia/b, open-label, multicentre, dose-escalation study of BI 905711 in patients with advanced gastrointestinal cancers |
| Meeting Title: | ESMO 22nd World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 Jul 1-4 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-01-01 |
| Start Page: | S145 |
| Language: | English |
| ACCESSION: | WOS:000558722000170 |
| DOI: | 10.1016/j.annonc.2020.04.251 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P-169 -- Source: Wos |
